Pharmacokinetics of a New Orodispersible Tablet Formulation of Vardenafil: Results of Three Clinical Trials

Background: Vardenafil is a potent and highly selective oral phosphodiesterase type 5 (PDE-5) inhibitor that has been shown in numerous clinical trials and post-marketing surveillance studies to be safe and effective for improving erectile function in men with erectile dysfunction (ED). Until recent...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical drug investigation 2011, Vol.31 (1), p.27-41
Hauptverfasser:	Heinig, Roland, Weimann, Boris, Dietrich, Hartmut, Böttcher, Michael-Friedrich
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Adult Age Factors Aged Aged, 80 and over Drug therapy Humans Imidazoles - administration & dosage Imidazoles - adverse effects Imidazoles - pharmacokinetics Impotence Internal Medicine Male Medicine Medicine & Public Health Middle Aged Original Research Article Pharmacokinetics Pharmacology/Toxicology Pharmacotherapy Phosphodiesterase 5 Inhibitors - administration & dosage Phosphodiesterase 5 Inhibitors - adverse effects Phosphodiesterase 5 Inhibitors - pharmacokinetics Piperazines - administration & dosage Piperazines - adverse effects Piperazines - pharmacokinetics Sulfones - administration & dosage Sulfones - adverse effects Sulfones - pharmacokinetics Tablets - administration & dosage Triazines - administration & dosage Triazines - adverse effects Triazines - pharmacokinetics Vardenafil Dihydrochloride
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!